Last reviewed · How we verify

NCT06721455

Modeling Blood Management and Hemolytic Risk in Pediatric Heart Surgery

Recruiting now Last updated 7 January 2026
What this trial tests

trial testing blood sampling in Heart Surgery in 50 participants. Currently enrolling.

Timeline
1 August 2025
Primary endpoint
31 December 2026
31 December 2026

Quick facts

Lead sponsorBoston Children's Hospital
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment50
Start date1 August 2025
Primary completion31 December 2026
Estimated completion31 December 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Boston Children's Hospital

Who can join

Adults 0 to 17, any sex, with Heart Surgery or Blood Transfusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to learn more about blood management in children undergoing heart surgery, such as the right amounts, and the best blood products, to administer. It also aims to develop a mathematical model that may help researchers better predict and treat patients who need blood transfusions during heart surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of blood sampling

Trials testing the same drug.

Other recruiting trials for Heart Surgery

Currently open trials in the same condition.

Other Boston Children's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06721455.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing